Axsome Therapeutics (AXSM) Misses Q1 EPS by 3c

Axsome Therapeutics (NASDAQ: AXSM) reported Q1 EPS of ($0.31), $0.03 worse than the analyst estimate of ($0.28).

For earnings history and earnings-related data on Axsome Therapeutics (AXSM) click here.

You May Also Be Interested In

• IBM plunges 19% as memory capex squeeze derails Q2 earnings
• Goldman Sachs on JPMorgan (JPM): 'We believe the results were modestly positive'
• Susquehanna Downgrades Canadian National Railway (CNI) to Neutral